ARTICLE | Company News
Isis Pharmaceuticals, Regulus Therapeutics LLC, Rosetta Genomics deal
September 29, 2008 7:00 AM UTC
Isis transferred to Regulus a 2006 partnership with Rosetta to discover and develop antisense candidates that regulate microRNAs to treat hepatocellular carcinoma. Regulus, a JV between Alnylam Pharm...